Glenmark Specialty Company Profile
✉ Email this page to a colleague
▶ Start for $1
Remove trial restrictions
What is the competitive landscape for GLENMARK SPECIALTY, and when can generic versions of GLENMARK SPECIALTY drugs launch?
GLENMARK SPECIALTY has one approved drug.
There are thirteen US patents protecting GLENMARK SPECIALTY drugs.
There are seventy patent family members on GLENMARK SPECIALTY drugs in thirty countries and eight supplementary protection certificates in seven countries.
Summary for Glenmark Specialty
International Patents: | 70 |
US Patents: | 13 |
Tradenames: | 1 |
Ingredients: | 1 |
NDAs: | 1 |
Drugs and US Patents for Glenmark Specialty
International Patents for Glenmark Specialty Drugs
Country | Patent Number | Estimated Expiration |
---|---|---|
Croatia | P20211515 | See Plans and Pricing |
Spain | 2849026 | See Plans and Pricing |
World Intellectual Property Organization (WIPO) | 2019162902 | See Plans and Pricing |
Norway | 2021045 | See Plans and Pricing |
Hong Kong | 1215674 | See Plans and Pricing |
>Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Glenmark Specialty Drugs
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
3043773 | 132021000000191 | Italy | See Plans and Pricing | PRODUCT NAME: MOMETASONE O UN SUO SALE E OLOPATADINA O UN SUO SALE(RYALTRIS); AUTHORISATION NUMBER(S) AND DATE(S): 048499014, 048499026, 048499038, 20210726;140638, 20210426 |
3043773 | CA 2021 00050 | Denmark | See Plans and Pricing | PRODUCT NAME: MOMETASON ELLER ET SALT DERAF OG OLOPATADIN ELLER ET SALT DERAF; NAT. REG. NO/DATE: 63820 20210706; FIRST REG. NO/DATE: AT 140638 20210426 |
0548114 | SPC/GB97/064 | United Kingdom | See Plans and Pricing | PRODUCT NAME: MOMETASONE FUROATE MONOHYDRATE; REGISTERED: FR AMM 343012.6 19970219; UK 00201/0216 19970410 |
3043773 | 122021000085 | Germany | See Plans and Pricing | PRODUCT NAME: MOMETASON ODER EIN SALZ DAVON UND OLOPATADIN ODER EIN SALZ DAVON; NAT. REGISTRATION NO/DATE: 2205824.00.00 20211117; FIRST REGISTRATION: OESTERREICH 140638 20210426 |
3043773 | 2022C/520 | Belgium | See Plans and Pricing | PRODUCT NAME: MOMETASONE OF EEN ZOUT HIERVAN EN OLOPATADINE OF EEN ZOUT HIERVAN; AUTHORISATION NUMBER AND DATE: BE595626 20220203 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Here is a list of applicants with similar names.